TNFalpha blockade in human diseases : mechanisms and future directions
Tumor necrosis factor-alpha (TNFalpha) antagonists have shown remarkable efficacy in a variety of immune-mediated inflammatory diseases (IMIDs). Therapeutic scope and limitations of these agents are reviewed in a recently published article in the Journal. In spite of their therapeutic popularity, li...
| Publié dans: | Clinical immunology (Orlando, Fla.). - 1999. - 126(2008), 2 vom: 01. Feb., Seite 121-36 |
|---|---|
| Auteur principal: | |
| Autres auteurs: | , , , , , , , , |
| Format: | Article |
| Langue: | English |
| Publié: |
2008
|
| Accès à la collection: | Clinical immunology (Orlando, Fla.) |
| Sujets: | Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review Anti-Inflammatory Agents, Non-Steroidal Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Antirheumatic Agents Cytokines Immunoglobulin G plus... |